Logo image
Back
A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids
Journal article   Open access   Peer reviewed

A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids

Dean G Karalis
Advances in therapy, v 34(2), pp 300-323
Feb 2017
DOI: https://doi.org/10.1007/s12325-016-0462-y
PMID: 27981496
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://link.springer.com/content/pdf/10.1007%2Fs12325-016-0462-y.pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.1007/s12325-016-0462-yView
Published, Version of Record (VoR) Open

Abstract

Cardiovascular Diseases - prevention & control Fatty Acids, Omega-3 - pharmacology Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology Hypertriglyceridemia - complications Hypertriglyceridemia - diagnosis Hypertriglyceridemia - drug therapy Pancreatitis - etiology Pancreatitis - prevention & control Practice Guidelines as Topic
Cardiovascular (CV) disease remains the leading cause of preventable death in the US. Hyperlipidemia is a major modifiable risk factor for CV disease, and after numerous clinical trials have demonstrated that reductions in low-density lipoprotein (LDL) cholesterol with statin therapy can prevent major adverse CV events, statins have emerged as the drug of choice to lower LDL cholesterol and reduce CV risk. However, some statin-treated patients remain at high residual risk of CV events despite achieving low LDL cholesterol levels, especially if their triglyceride (TG) levels are elevated or their high-density lipoprotein (HDL) cholesterol levels low. Evidence from genetic and observational studies has linked elevated TG levels to an increased risk of CV events. Furthermore, very high TG levels are associated with acute pancreatitis. Consequently, several clinical practice guidelines provide recommendations for the management and treatment of high and very high TG levels. This review focuses on the clinical practice guidelines for the management of hypertriglyceridemia and the role of prescription omega-3 fatty acids in preventing pancreatitis and CV disease in individuals with high and very high TG levels.

Metrics

13 Record Views
31 citations in Web of Science
35 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Medicine, Research & Experimental
Pharmacology & Pharmacy
Logo image